Jonas F Ludvigsson, a pediatrician in Örebro and professor of epidemiology at the Karolinska Institute, has been awarded an honorary distinction by the foundation Forska Sverige for his scientific integrity and his defense of academic freedom, Expressen reports. The recognition comes years after his COVID-19 research triggered a wave of hostility, including harassment and repeated misconduct reports.
According to Expressen, Ludvigsson describes the period as "a personal tsunami," an experience intense enough that he eventually stopped researching and commenting publicly on COVID-19. The award, reported on October 20, 2026, singles out his willingness to stand behind research findings even under heavy pressure.
Why it matters
The case touches on a question central to public health: how researchers communicate findings that are accurate but unwelcome. Expressen reports that Ludvigsson's studies were not withdrawn and that he was cleared of the misconduct allegations against him. His experience illustrates the cost that can accompany scientific communication during a polarized crisis, and the award places that cost in a wider debate about academic freedom.
Forska Sverige's secretary-general, Anna Nilsson Vindefjärd, told Expressen that Ludvigsson regards defending science as an obligation even when it becomes difficult, and that he does so out of concern for patients. She said researchers of his kind are badly needed.
From early pandemic findings to a wave of hostility
Ludvigsson's main research field is gastrointestinal disease, and Expressen notes he has also published lighter studies, including work on illnesses in the Harry Potter books and on whether eating gingerbread cookies makes people kinder (it does not). As a pediatrician with an interest in history and current events, he picked up news of covid-19 early.
He decided to compile a systematic review of research studies. Its conclusion, according to Expressen, was that children in the early phase of the pandemic neither became seriously ill to any great extent nor drove transmission significantly. That finding, he told the newspaper, made him unpopular in some circles, and harassment began in the autumn of 2020.
The pressure escalated in early 2021, when the New England Journal of Medicine published a short Swedish study. Ludvigsson and three colleagues had reviewed all children treated in intensive care in Sweden during a period when schools remained open for those age groups. Their conclusion was that extremely few children received intensive care for covid-19, and some of those treated were in intensive care for another reason while also having the virus.
The study drew enormous attention, and with it what Ludvigsson described to Expressen as a tsunami of hate in emails and on social media. Prominent researchers called for the paper to be retracted, and he was reported for research misconduct several times. He told the newspaper he believed his research career was over, and that the tone was harsh and undignified. In his account, the dispute was not about differing interpretations of studies but about dislike of their results.
Expressen reports that the study remains published and that Ludvigsson was cleared of the misconduct suspicions. Today he finds it easier to discuss how difficult that period was.
A continued commitment to public communication
The episode did not end his engagement with the public. Expressen reports that he continues to answer journalists' questions, meet patient groups, write books and post on LinkedIn to convey what is known on various subjects. The day after the interview, he was scheduled to lecture on the importance of childhood vaccination.
He told the newspaper that communicating research results is part of a researcher's job, but that it is equally important not to overstate findings and to acknowledge uncertainty. He said he only agrees to take part when he has read up sufficiently on the topic.
Ludvigsson has also taken on other contentious subjects. Expressen reports he served as a medical expert in SBU's review of hormone treatment for children and young people with gender dysphoria, which concluded that knowledge about side effects was lacking. He recalled that a friend questioned his judgment when he was asked, and that he accepted because someone was needed to represent the child perspective, even though he understood the criticism would be fierce.
The award is not his first recognition; Expressen notes he has received several prizes and distinctions, including a medal from the king. But he told the newspaper that an honor tied to defending academic freedom carries particular weight, especially as free research faces growing constraints in the United States following Donald Trump's return to the presidency. He said the prize is not for the best or most-cited paper but a recognition of many years of work, and that it feels significant.
The Expressen article was written by Amina Manzoor, the outlet's science commentator, who focuses on vaccines, public health and pandemics and has written a book on the covid pandemic.
What to watch next is whether the honor shifts the broader conversation about how institutions and publishers respond when research findings provoke organized backlash, and whether Ludvigsson's cleared record and continuing public engagement encourage other researchers to speak on contested topics.
